{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:13:22Z","timestamp":1772079202825,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007482","name":"Arizona State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011112","name":"UCB Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.yebeh.2021.108473","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T04:31:15Z","timestamp":1639542675000},"page":"108473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The influence of social determinants of health on epilepsy treatment delays in an Arizona Medicaid population"],"prefix":"10.1016","volume":"126","author":[{"given":"Joseph","family":"Sirven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Sprout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Speer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Simic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Ems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gevork","family":"Harootunian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108473_b0005","doi-asserted-by":"crossref","first-page":"e2197","DOI":"10.1212\/WNL.0000000000007448","article-title":"Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US","volume":"92","author":"Kalilani","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108473_b0010","series-title":"Social determinants of health","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.yebeh.2021.108473_b0015","unstructured":"Healthy People 2020: Social Determinants of Health. Office of Disease Prevention and Health Promotion; n.d."},{"key":"10.1016\/j.yebeh.2021.108473_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1377\/hlthaff.21.2.60","article-title":"Socioeconomic disparities in health: pathways and policies","volume":"21","author":"Adler","year":"2002","journal-title":"Health Aff"},{"key":"10.1016\/j.yebeh.2021.108473_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0304-4076(02)00145-8","article-title":"Healthy, wealthy, and wise? Tests for direct causal paths between health and socioeconomic status","volume":"112","author":"Adams","year":"2003","journal-title":"Journal of Econometrics"},{"key":"10.1016\/j.yebeh.2021.108473_b0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108473_b0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.09.064147","article-title":"Global disparities in the epilepsy treatment gap: a systematic review","volume":"88","author":"Meyer","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.yebeh.2021.108473_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1528-1157.2001.32800.x","article-title":"The treatment gap in epilepsy: the current situation and ways forward","volume":"42","author":"Meinardi","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108473_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2018.05.019","article-title":"Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis","volume":"85","author":"Faught","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108473_b0050","doi-asserted-by":"crossref","unstructured":"Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults 2015:10.","DOI":"10.1212\/WNL.0000000000001487"},{"key":"10.1016\/j.yebeh.2021.108473_b0055","unstructured":"Overview | Epilepsies: diagnosis and management | Guidance | NICE n.d. https:\/\/www.nice.org.uk\/guidance\/cg137 (accessed April 8, 2020)."},{"key":"10.1016\/j.yebeh.2021.108473_b0060","unstructured":"American Epilepsy Society. FAQs. American Epilepsy Society 2013. https:\/\/www.aesnet.org\/clinical_resources\/faqs (accessed May 17, 2020)."},{"key":"10.1016\/j.yebeh.2021.108473_b0065","unstructured":"American Epilepsy Society. Summary of Antiepileptic Drugs Available in the U.S. American Epilepsy Society 2018. https:\/\/www.aesnet.org\/clinical_resources\/aedchart (accessed April 15, 2020)."},{"key":"10.1016\/j.yebeh.2021.108473_b0070","unstructured":"Epilepsy Foundation. Epilepsy Pipeline Tracker. Epilepsy Foundation 2021. https:\/\/www.epilepsy.com\/pipeline-listing-page (accessed May 17, 2020)."},{"key":"10.1016\/j.yebeh.2021.108473_b0075","series-title":"Statistical methods in diagnostic medicine","author":"Zhou","year":"2009"},{"key":"10.1016\/j.yebeh.2021.108473_b0080","unstructured":"AHCCCS \u2013 Demographics, Social Determinants and Outcomes n.d. https:\/\/www.azahcccs.gov\/PlansProviders\/Demographics\/ (accessed April 18, 2021)."},{"issue":"2","key":"10.1016\/j.yebeh.2021.108473_b0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2021.108473_b0090","series-title":"Care without coverage: too little, too late","author":"Committee on the Consequences of Uninsurance","year":"2002"},{"key":"10.1016\/j.yebeh.2021.108473_b0095","unstructured":"Medicaid.gov. Managed Care in Arizona. Medicaid.gov; 2014."},{"key":"10.1016\/j.yebeh.2021.108473_b0100","series-title":"Competition among managed care plans lowers program costs","author":"Medicaid","year":"1995"},{"key":"10.1016\/j.yebeh.2021.108473_b0105","unstructured":"National Health Policy Forum: Managed Medicaid - Arizona\u2019s AHCCCS Experience. 2000."},{"key":"10.1016\/j.yebeh.2021.108473_b0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-publhealth-031210-101218","article-title":"The social determinants of health: coming of age","volume":"32","author":"Braveman","year":"2011","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.yebeh.2021.108473_b0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2019.10915","article-title":"Screening for social determinants of health: the known and unknown","volume":"322","author":"Davidson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2021.108473_b0120","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1528-1167.2009.02282.x","article-title":"Disparities in epilepsy: Report of a systematic review by the North American Commission of the International League Against Epilepsy","volume":"50","author":"Burneo","year":"2009","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021007344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021007344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:43:39Z","timestamp":1761504219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021007344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"alternative-id":["S1525505021007344"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108473","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of social determinants of health on epilepsy treatment delays in an Arizona Medicaid population","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108473"}}